SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Brecher M, Banks PM. Hodgkin's disease variant of Richter's syndrome. Report of eight cases. Am J Clin Pathol. 1990; 93: 333339.
  • 2
    Ohno T, Smir BN, Weisenburger DD, Gascoyne RD, Hinrichs SD, Chan WC. Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with “Hodgkin's transformation.” Blood. 1998; 91: 17571761.
  • 3
    Momose H, Jaffe ES, Shin SS, Chen YY, Weiss LM. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol. 1992; 16: 859867.
  • 4
    Williams J, Schned A, Cotelingam JD, Jaffe ES. Chronic lymphocytic leukemia with coexistent Hodgkin's disease. Implications for the origin of the Reed-Sternberg cell. Am J Surg Pathol. 1991; 15: 3342.
  • 5
    Shin SS, Ben-Ezra J, Burke JS, Sheibani K, Rappaport H. Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage. Am J Clin Pathol. 1993; 99: 658662.
  • 6
    Fayad L, Robertson LE, O'Brien S, et al. Hodgkin's disease variant of Richter's syndrome: experience at a single institution. Leuk Lymphoma. 1996; 23: 333337.
  • 7
    Weisenberg E, Anastasi J, Adeyanju M, Variakojis D, Vardiman JW. Hodgkin's disease associated with chronic lymphocytic leukemia. Eight additional cases, including two of the nodular lymphocyte predominant type. Am J Clin Pathol. 1995; 103: 479484.
  • 8
    Tsang WY, Chan JK, Sing C. The nature of Reed-Sternberg-like cells in chronic lymphocytic leukemia. Am J Clin Pathol. 1993; 99: 317323.
  • 9
    Choi H, Keller RH. Coexistence of chronic lymphocytic leukemia and Hodgkin's disease. Cancer. 1981; 48: 4857.
  • 10
    Butts C, Drouin J, Taylor R, McLeish W. Hodgkin's disease in CLL. Am J Hematol. 1995; 48: 134135.
  • 11
    Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol. 2005; 23: 50275033.
  • 12
    Tsimberidou AM, O'Brien S, Khouri I, et al. Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem cell transplantation. J Clin Oncol. 2006; 24: 23432351.
  • 13
    Seymour JF, Campbell J. Richter's syndrome. In: ChesonBD, editor. Chronic Lymphoid Leukemias. 2nd ed. New York: Marcel Dekker, Inc.; 2001: 459483.
  • 14
    Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998; 339: 15061514.
  • 15
    Travis LB, Curtis RE, Hankey BF, Fraumeni JFJr. Second cancers in patients with chronic lymphocytic leukemia. J Natl Cancer Inst. 1992; 84: 14221427.
  • 16
    Cheson BD, Vena DA, Barrett J, Freidlin B. Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias. J Clin Oncol. 1999; 17: 24542460.
  • 17
    Juneja S, Carney D, Ellis D, Januszewicz EH, Wolf M, Prince HM. Hodgkin's disease type Richter's syndrome in chronic lymphocytic leukemia. Leukemia. 1999; 13: 826827.
  • 18
    Pescarmona E, Pignoloni P, Mauro FR, et al. Hodgkin/Reed-Sternberg cells and Hodgkin's disease in patients with B-cell chronic lymphocytic leukaemia: an immunohistological, molecular and clinical study of four cases suggesting a heterogeneous pathogenetic background. Virchows Arch. 2000; 437: 129132.
  • 19
    Hansmann ML, Fellbaum C, Hui PK, Lennert K. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease. Histopathology. 1989; 15: 3548.
  • 20
    Robak T, Szmigielska-Kaplon A, Smolewski P, et al. Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide. Leuk Lymphoma. 2003; 44: 859866.
  • 21
    Zinzani PL, Tani M, Stefoni V, et al. From chronic lymphocytic leukemia to Hodgkin's disease: a case of prognostically favorable transformation. Leuk Res. 2002; 26: 775776.
  • 22
    Nemets A, Ben Dor D, Barry T, et al. Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine. Leuk Lymphoma. 2003; 44: 21512154.
  • 23
    Alliot C, Tabuteau S, Desablens B. Hodgkin's disease variant of Richter's syndrome: complete remission of the both malignancies after 14 years. Hematology. 2003; 8: 229221.
  • 24
    Serratrice De Roux C, Coso D, Bouabdallah R, Serratrice J, Disdier P, Weiller PJ. Chronic lymphocytic leukemia and Hodgkin's disease. Clinicopathologic study of three cases with good prognosis. Haematologica. 2000; 85: 878879.
  • 25
    Schmidt HH, Sill H, Eibl M, et al. Hodgkin's disease developing after spontaneous remission of chronic lymphocytic leukemia. Ann Hematol. 1995; 71: 247252.
  • 26
    Rubin D, Hudnall SD, Aisenberg A, Jacobson JO, Harris NL. Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr virus infection. Mod Pathol. 1994; 7: 9198.
  • 27
    Petrella T, Yaziji N, Collin F, et al. Implication of the Epstein-Barr virus in the progression of chronic lymphocytic leukaemia/small lymphocytic lymphoma to Hodgkin-like lymphomas. Anticancer Res. 1997; 17: 39073913.
  • 28
    de Leval L, Vivario M, De Prijck B, et al. Distinct clonal origin in two cases of Hodgkin's lymphoma variant of Richter's syndrome associated With EBV infection. Am J Surg Pathol. 2004; 28: 679686.
  • 29
    Hochster H, Weller E, Kuzel T, Frankel S, Horning S. Increased mortality associated with higher dose cyclophosphamide plus fludarabine in advanced stage indolent lymphoma patients treated on E1496, an ECOG and CALGB study. Proc Am Soc Clin Oncol. 2002; 21: 282a. Abstract.
  • 30
    Diehl V, Franklin J, Pfreundschuh M, et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med. 2003; 348: 23862395.
  • 31
    Schmitz N, Pfistner B, Sextro M, et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet. 2002; 359: 20652071.
  • 32
    Linch DC, Winfield D, Goldstone AH, et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial. Lancet. 1993; 341: 10511054.